<H1>
MSF calls on all governments to support landmark move at WTO to suspend monopolies during COVID-19
</H1> |
<H2> Latest news </H2> |
<H2> Key publications </H2> |
<H2>
Step Up for TB: TB policies in 37 countries, 4th Ed.
</H2> |
<H2>
DR-TB and TB-Prevention Drugs Under the Microscope, 7th Edition
</H2> |
<H2>
A century of neglect: challenges of access to insulin for diabetes care
</H2> |
<H2>
A Fair Shot for Vaccine Affordability
</H2> |
<H2> MSF Access Campaign work on COVID-19 </H2> |
<H2>
MSF calls on all governments to support landmark move at WTO to suspend monopolies during COVID-19
</H2> |
<H2>
5 reasons a new proposal by India and South Africa could be a gamechanger in the COVID-19 response
</H2> |
<H2>
COVID-19 vaccine: 6 recommendations for equitable access
</H2> |
<H2>
MSF responds to emergency use authorization for REGN-CoV-2 by the US FDA
</H2> |
<H2>
Over 100 civil society organisations call on the European Parliament to support COVID-19 WTO waiver proposal
</H2> |
<H2>
India and South Africa proposal for WTO waiver from IP protections for COVID-19-related medical technologies
</H2> |
<H2>
MSF: Governments must demand pharma make all COVID-19 vaccine licensing deals public
</H2> |
<H2>
MSF Statement for WHO Executive Board Special Session on COVID-19 Response
</H2> |
<H2> Our work </H2> |
<H2> Read, watch, share </H2> |
<H2>
DR-TB and TB-Prevention Drugs Under the Microscope, 7th Edition
</H2> |
<H2>
5 reasons a new proposal by India and South Africa could be a gamechanger in the COVID-19 response
</H2> |
<H2>
Patent Oppositions Database
</H2> |
<H2>
COVID-19 vaccine: 6 recommendations for equitable access
</H2> |
<H2>
5 barriers from Big Pharma preventing people getting lifesaving TB drugs
</H2> |
<H2>
How Big Pharma is making people pay twice for many of the medicines they buy
</H2> |
<H2>
A silent woman-killer in Malawi
</H2> |
<H2>
Access to Insulin: Towards a WHA Resolution
</H2> |
<H2> Join the conversation </H2> |
<H2>
#Kenya is supporting the movement to put lives over profits in the #COVID19 pandemic! Which countries will do the right thing and support the proposal to remove pharma monopolies on #COVID19 medical tools? #NoCovidMonopolies bit.ly/3lNiZwA
</H2> |
<H2>
@WTO will resume its informal session of the TRIPS Council today at 10 AM to discuss the TRIPS waiver. At the same time, @WIPO will convene its Coordination Committee to appoint the new members of the senior management team. keionline.org/34715 @MSF_access @IFLA @South_Centre
</H2> |
<H2>
HIV medicine is much more affordable than 20 years ago, but children and babies living with HIV have been left behind.We need to do everything possible to get HIV meds that are adapted for children to all who need them. 👶🏿👶🏾👶🏼👶🏻 #WorldAidsDay2020 bit.ly/3fPEdrd
</H2> |
<H2>
Only half of the almost 2 million children & babies living with HIV worldwide are taking lifesaving antiretroviral treatment.Children and babies with HIV deserve access to the best treatment possible. Learn more ⬇️ #WorldAidsDay2020 bit.ly/3fPEdrd
</H2> |
<H2>
20 years after civil society had a global revolt for access to affordable HIV drugs, 12 million people around the 🌍 cannot access lifesaving antiretrovirals ➡️ msfaccess.org/worldwide-revo…Read the Untangling the Web report ⬇️ #WorldAidsDay2020 bit.ly/3fPEdrd
</H2> |
<H2>
What good are new vaccines & tools for #COVID19 if the people who need them can’t access them? This pandemic isn’t over until it’s over for everyone. That’s why @MSF says NO to patents in this pandemic. ⬇️ bit.ly/38Px6xz #NoCovidMonopolies
</H2> |
<H2>
Lifesaving tools developed for #COVID19 should be accessible for all, not a luxury for the few. MSF is supporting the call to suspend monopolies on all COVID-19 medical tools. ⬇️ #NoCovidMonopolies bit.ly/38Px6xz
</H2> |
<H2>
“Nobody can afford to let corporations that have been supported by billions in publicly funded research money to simply pursue their bottom line interests without regard to global #COVID19 needs.” MSF’s @CandisiweS in @dailymaverick #NoCovidMonopolies👇 bit.ly/33oK9T4
</H2> |
<H2>
Lives Over Profit: a Patient, a Doctor and a Lawyer Take Action
</H2> |
<H3>
Untangling the Web: HIV Medicine Pricing & Access Issues, 2020
</H3> |
<H3>
MSF welcomes EU pharmaceutical strategy but challenges key intellectual property issue
</H3> |
<H3>
MSF responds to emergency use authorization for REGN-CoV-2 by the US FDA
</H3> |
<H3>
AstraZeneca must open books to prove ‘no-profit’ pricing commitment and make all licenses and agreements public
</H3> |
<H3>
Over 100 civil society organisations call on the European Parliament to support COVID-19 WTO waiver proposal
</H3> |
<H3>
India and South Africa proposal for WTO waiver from IP protections for COVID-19-related medical technologies
</H3> |
<H3>
MSF: Moderna must transparently share information around their COVID-19 vaccine and sell it at-cost
</H3> |
<H3>
Report shows new tests and drugs for world’s deadliest infectious disease, TB, remain out of reach
</H3> |
<H3>
MSF: Governments must demand pharma make all COVID-19 vaccine licensing deals public
</H3> |
<H3>
MSF welcomes Fiocruz’s step towards transparency of AstraZeneca deal
</H3> |
<H3>
MSF response to Gavi’s intent to purchase Sanofi-GSK COVID-19 vaccine candidate for the COVAX Facility
</H3> |
<H3>
DR-TB and TB-Prevention Drugs Under the Microscope, 7th Edition
</H3> |
Social
Social Data
Cost and overhead previously rendered this semi-public form of communication unfeasible.
But advances in social networking technology from 2004-2010 has made broader concepts of sharing possible.